Jeff Yass’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,655
| Closed | -$2.49M | – | 13804 |
|
|
2025
Q1 | $2.14M | Sell |
33,655
-77,690
| -70% | -$4.65M | ﹤0.01% | 5380 |
|
|
2024
Q4 | $5.17M | Buy |
+111,345
| New | +$4.18M | ﹤0.01% | 3529 |
|
|
2024
Q3 | – | Sell |
-117,397
| Closed | -$2.89M | – | 13134 |
|
|
2024
Q2 | $1.7M | Buy |
+117,397
| New | +$1.71M | ﹤0.01% | 5414 |
|
|
2023
Q4 | – | Sell |
-10,607
| Closed | -$157K | – | 13387 |
|
|
2023
Q3 | $173K | Sell |
10,607
-31,040
| -75% | -$598K | ﹤0.01% | 10392 |
|
|
2023
Q2 | $880K | Buy |
+41,647
| New | +$888K | ﹤0.01% | 6995 |
|
|
2023
Q1 | – | Sell |
-74,283
| Closed | -$1.6M | – | 13571 |
|
|
2022
Q4 | $1.94M | Buy |
+74,283
| New | +$989K | ﹤0.01% | 4757 |
|
|
2022
Q2 | – | Sell |
-18,333
| Closed | -$78.4K | – | 14042 |
|
|
2022
Q1 | $91K | Sell |
18,333
-12,447
| -40% | -$72.4K | ﹤0.01% | 11976 |
|
|
2021
Q4 | $207K | Buy |
30,780
+15,416
| +100% | +$78.8K | ﹤0.01% | 11375 |
|
|
2021
Q3 | $84K | Buy |
+15,364
| New | +$89.4K | ﹤0.01% | 12158 |
|
|
2021
Q2 | – | Sell |
-15,035
| Closed | -$126K | – | 13328 |
|
|
2021
Q1 | $126K | Buy |
15,035
+2,998
| +25% | +$24.9K | ﹤0.01% | 11750 |
|
|
2020
Q4 | $84K | Buy |
+12,037
| New | +$81.3K | ﹤0.01% | 10581 |
|
|
2020
Q1 | – | Sell |
-15,375
| Closed | -$88K | – | 10955 |
|
|
2019
Q4 | $88K | Buy |
+15,375
| New | +$67.2K | ﹤0.01% | 9189 |
|
Other funds holding VRNA
Jeff Yass's VRNA Position: Q2 2025 in Review
Jeff Yass sold out of Verona Pharma (VRNA) in Q2 2025, closing a stake of 33,655 shares — an estimated $2.49M sold.
Jeff Yass first reported a position in VRNA in Q4 2019 and held it in 12 quarters. The position peaked at $5.17M in Q4 2024. 292 funds tracked by Wall St. Rank hold VRNA as of Q2 2025.
- Jeff Yass reported no remaining Verona Pharma position as of Q2 2025 after selling out during the quarter.
- Jeff Yass sold 33,655 Verona Pharma shares in Q2 2025, an estimated $2.49M.
- Jeff Yass first reported a position in Verona Pharma in Q4 2019 and held it in 12 quarters.
- Jeff Yass's Verona Pharma position peaked at $5.17M in Q4 2024.
- 292 funds tracked by Wall St. Rank held Verona Pharma as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.